Kestra Advisory Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $342K | Sell |
|
|||||
|
2025
Q2 | $314K | Sell |
|
|||||
|
2025
Q1 | $371K | Buy |
|
|||||
|
2024
Q4 | $337K | Sell |
|
|||||
|
2024
Q3 | $377K | Sell |
|
|||||
|
2024
Q2 | $360K | Buy |
|
|||||
|
2024
Q1 | $328K | Buy |
|
|||||
|
2023
Q4 | $294K | Buy |
|
|||||
|
2023
Q3 | $274K | Sell |
|
|||||
|
2023
Q2 | $289K | Buy |
|
|||||
|
2023
Q1 | $251K | Sell |
|
|||||
|
2022
Q4 | $292K | Buy |
|
|||||
|
2022
Q3 | $259K | Sell |
|
|||||
|
2022
Q2 | $316K | Buy |
|
|||||
|
2022
Q1 | $303K | Buy |
|
|||||
|
2021
Q4 | $309K | Sell |
|
|||||
|
2021
Q3 | $329K | Buy |
|
|||||
|
2021
Q2 | $248K | Buy |
|
|||||
|
2021
Q1 | $237K | Sell |
|
|||||
|
2020
Q4 | $312K | Buy |
|